M. Castiñeira

Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

R. Hermida, J. Fernandez, A. Moyá, 2020, Chronobiology International.

The Hygia Project and Hygia Chronotherapy Trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health

A. Moyá, J. J. Crespo, M. T. Ríos, 2020, Chronobiology international.

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.

R. Hermida, D. Ayala, J. Fernandez, 2019, European heart journal.

Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk.

R. Hermida, D. Ayala, J. Fernandez, 2018, European heart journal.

Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention

R. Hermida, D. Ayala, A. Moyá, 2018, European heart journal.

Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure.

M. Smolensky, R. Hermida, D. Ayala, 2020, Revista espanola de cardiologia.